Among these, CD44 expression levels (p = .0013) were greater in T2DM patients than in controls, but BCAT2 expression levels (p = .043), HILPDA expression levels (p = .044), and MYCN expression levels (p = 4e‐06) were lower in T2DM patients. The gene discussed is MYCN; the disease is type 2 diabetes mellitus.